BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23429468)

  • 1. End-stage liver disease complications.
    Rahimi RS; Rockey DC
    Curr Opin Gastroenterol; 2013 May; 29(3):257-63. PubMed ID: 23429468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications of cirrhosis.
    Rahimi RS; Rockey DC
    Curr Opin Gastroenterol; 2012 May; 28(3):223-9. PubMed ID: 22343347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications and outcomes in chronic liver disease.
    Rahimi RS; Rockey DC
    Curr Opin Gastroenterol; 2011 May; 27(3):204-9. PubMed ID: 21451410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review.
    Garcia-Tsao G; Abraldes JG; Rich NE; Wong VW
    Gastroenterology; 2024 Jan; 166(1):202-210. PubMed ID: 37978969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
    Krag A; Borup T; Møller S; Bendtsen F
    Adv Ther; 2008 Nov; 25(11):1105-40. PubMed ID: 19018483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and Management of Cirrhosis and Its Complications: A Review.
    Tapper EB; Parikh ND
    JAMA; 2023 May; 329(18):1589-1602. PubMed ID: 37159031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of liver diseases in Korea: liver cirrhosis.
    Jang JW
    Korean J Hepatol; 2009 Dec; 15 Suppl 6():S40-9. PubMed ID: 20037279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of end-stage liver disease.
    Perri GA; Khosravani H
    Can Fam Physician; 2016 Jan; 62(1):44-50. PubMed ID: 26796834
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary Prophylaxis to Prevent the Development of Hepatic Encephalopathy in Cirrhotic Patients with Acute Variceal Bleeding.
    Higuera-de-la-Tijera F; Servín-Caamaño AI; Salas-Gordillo F; Pérez-Hernández JL; Abdo-Francis JM; Camacho-Aguilera J; Alla SN; Jiménez-Ponce F
    Can J Gastroenterol Hepatol; 2018; 2018():3015891. PubMed ID: 30079329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of patients with complications of cirrhosis.
    Fowler C
    Nurse Pract; 2013 Apr; 38(4):14-21; quiz 22-3. PubMed ID: 23454902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in critical care hepatology.
    Volk ML; Marrero JA
    Minerva Anestesiol; 2006 May; 72(5):269-81. PubMed ID: 16675936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactulose a day keeps encephalopathy at bay.
    Klinken E; MacQuillan G
    J Gastroenterol Hepatol; 2011 Jun; 26(6):939-40. PubMed ID: 21564285
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of portal hypertension on prognosis in patients with decompensated liver cirrhosis].
    Zhang JY; Kuai JH; Jia JD; Wang BE; Qin CY
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):263-5. PubMed ID: 19403023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Agrawal A; Sharma BC; Sarin SK
    J Gastroenterol Hepatol; 2011 Jun; 26(6):996-1003. PubMed ID: 21129028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study.
    Jepsen P; Ott P; Andersen PK; Sørensen HT; Vilstrup H
    Hepatology; 2010 May; 51(5):1675-82. PubMed ID: 20186844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Factors for the Prognosis of Alcoholic Liver Cirrhosis.
    Trifan A; Minea H; Rotaru A; Stanciu C; Stafie R; Stratina E; Zenovia S; Nastasa R; Singeap AM; Girleanu I; Muzica C; Huiban L; Cuciureanu T; Chiriac S; Sfarti C; Cojocariu C
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis.
    Bajaj JS
    Aliment Pharmacol Ther; 2016 Jan; 43 Suppl 1():11-26. PubMed ID: 26618922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of terlipressin in critically ill children with liver disease.
    Saxena R; Anand A; Deep A
    BMC Nephrol; 2020 Aug; 21(1):360. PubMed ID: 32819297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome.
    Saner FH; Canbay A; Gerken G; Broelsch CE
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):207-17. PubMed ID: 19072411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
    Mittal VV; Sharma BC; Sharma P; Sarin SK
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.